Eve Health Group Stock Fundamentals
EVE Stock | 0 0.00 0.00% |
EVE Health Group fundamentals help investors to digest information that contributes to EVE Health's financial success or failures. It also enables traders to predict the movement of EVE Stock. The fundamental analysis module provides a way to measure EVE Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EVE Health stock.
At this time, EVE Health's Interest Expense is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 2.4 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.8 M in 2024. EVE | Select Account or Indicator |
EVE Health Group Company Operating Margin Analysis
EVE Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current EVE Health Operating Margin | (0.75) % |
Most of EVE Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EVE Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, EVE Health Group has an Operating Margin of -0.7484%. This is 97.73% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The operating margin for all Australia stocks is 86.42% lower than that of the firm.
EVE Health Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EVE Health's current stock value. Our valuation model uses many indicators to compare EVE Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EVE Health competition to find correlations between indicators driving EVE Health's intrinsic value. More Info.EVE Health Group is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EVE Health's earnings, one of the primary drivers of an investment's value.EVE Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EVE Health's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EVE Health could also be used in its relative valuation, which is a method of valuing EVE Health by comparing valuation metrics of similar companies.EVE Health is currently under evaluation in operating margin category among its peers.
EVE Fundamentals
Return On Equity | -0.71 | ||||
Return On Asset | -0.3 | ||||
Profit Margin | (0.89) % | ||||
Operating Margin | (0.75) % | ||||
Current Valuation | 5.24 M | ||||
Shares Outstanding | 5.27 B | ||||
Shares Owned By Insiders | 51.24 % | ||||
Price To Book | 4.31 X | ||||
Price To Sales | 2.47 X | ||||
Revenue | 2.13 M | ||||
Gross Profit | 827.83 K | ||||
EBITDA | (1.51 M) | ||||
Net Income | (1.55 M) | ||||
Cash And Equivalents | 1.1 M | ||||
Total Debt | 74.85 K | ||||
Cash Flow From Operations | (1.11 M) | ||||
Beta | 0.94 | ||||
Market Capitalization | 5.27 M | ||||
Total Asset | 2.52 M | ||||
Retained Earnings | (34.8 M) | ||||
Working Capital | 1.22 M | ||||
Net Asset | 2.52 M |
About EVE Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EVE Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EVE Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EVE Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 326 K | 342.3 K | |
Total Revenue | 2.1 M | 1.4 M | |
Cost Of Revenue | 1.3 M | 1.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.